文献速递炎症性肠病

瑞典1990至2014年炎症性肠病发病率的全国性队列研究

A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014.
PubMed 文献 · Aliment Pharmacol Ther · 2021-12-14

该全国性队列研究基于ESPRESSO队列中1990至2014年的诊断编码与活检报告,评估瑞典炎症性肠病(IBD)的发病率与时间趋势。共识别65 908例新发IBD,整体发病率为29.0/10万人年,IBD、溃疡性结肠炎(UC)和克罗恩病(CD)年发病率在1990至2001年间每年增加约7%,2002年起每年下降1%–2%。男女终生IBD风险均约2.5%。

要点

  • 1990至2014年瑞典共识别65 908例新发IBD,整体发病率为29.0/10万人年。
  • IBD、UC和CD年发病率在1990至2001年间每年增加约7%,2002年起每年下降1%–2%。
  • 男女终生IBD风险均约2.5%,约每40人中1人一生中被诊断为IBD。

核心结论

  • 在瑞典,所有亚型IBD的发病率在1990至2001年间上升,此后下降。
  • 约每40人中1人预期在一生中被诊断为IBD。

研究设计与样本

  • 全国性队列研究,基于ESPRESSO队列中1990至2014年登记的IBD诊断编码与活检报告。
  • 计算年龄别和年龄标准化发病率及累积发病率。

主要发现

  • 共识别65 908例新发IBD:UC 38 261例(58%)、CD 18 577例(28%)、IBD-U 9 070例(14%)。
  • 1990至2014年整体发病率每10万人年:IBD 29.0(95%CI 27.3–30.7)、UC 16.9(95%CI 15.9–17.9)、CD 8.1(95%CI 7.7–8.6)。
  • IBD-U在2002至2014年的发病率为5.2(95%CI 4.9–5.6)。
  • IBD、UC和CD年发病率在1990至2001年间每年增加约7%(P<0.001),2002年起每年下降1%–2%(P<0.001)。
  • IBD、UC和IBD-U的发病率男性高于女性,而CD的发病率女性高于男性;男女终生IBD风险均约2.5%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epidemiological studies have shown inconsistent incidence rates (IRs) for inflammatory bowel disease (IBD). AIM: To assess the incidence and temporal trends of IBD in Sweden. METHODS: Nationwide cohort study based on diagnostic codes for IBD and biopsy reports registered through the ESPRESSO cohort in 1990-2014. Age-specific and age-standardised IRs and cumulative incidence were calculated. RESULTS: Overall, we identified 65 908 cases of incident IBD: ulcerative colitis (UC, n = 38 261, 58%), Crohn's disease (CD, n = 18 577, 28%) and IBD-U (n = 9070, 14%). During 1990-2014, the overall IRs per 100 000 person-years were 29.0 (95% CI: 27.3-30.7) for IBD, 16.9 (15.9-17.9) for UC, and 8.1 (7.7-8.6) for CD. For IBD-U, the IR was 5.2 (4.9-5.6) in 2002-2014. The annual incidence of IBD, UC and CD increased by approximately 7% per year between 1990 and 2001 (P < 0.001) and then decreased by 1%-2% per year from 2002 onwards (P < 0.001). IRs for IBD, UC and IBD-U were higher in males while the IR for CD was higher in females. The lifetime risk of IBD was about 2.5% for both sexes. CONCLUSIONS: In Sweden, the incidence of IBD in all subtypes increased in 1990-2001 but has since declined. One in 40 individuals is expected to be diagnosed with IBD during their lifetime.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Forss A, Clements M, Bergman D, et al. A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014. Aliment Pharmacol Ther. 2021. PMID: 34907544. doi:10.1111/apt.16735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。